Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Vulvar Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 12Radiotherapy 8Cisplatin 8pembrolizumab 4Papillomavirus Vaccines 4Mitomycin 4Irinotecan 4Cyclophosphamide 4Cetuximab 4Light Coagulation 3Interleukin-12 Subunit p35 3Capecitabine 3fludarabine phosphate 2fludarabine 2atezolizumab 2aldesleukin 2Watchful Waiting 2Vaccines 2Trastuzumab 2Surveys and Questionnaires 2Radiation 2Quality of Life 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2Early Intervention, Educational 2Carboplatin 2Biopsy 2toripalimab 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anus Neoplasms × E6 protein, Human papillomavirus type 16 × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡